Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 12

1.

Relationship of age, prostate-specific antigen, and prostate volume in Indonesian men with benign prostatic hyperplasia.

Putra IB, Hamid AR, Mochtar CA, Umbas R.

Prostate Int. 2016 Jun;4(2):43-8. doi: 10.1016/j.prnil.2016.03.002. Epub 2016 Mar 11.

2.

Genetic Determinants of Metabolism and Benign Prostate Enlargement: Associations with Prostate Volume.

Giri A, Edwards TL, Motley SS, Byerly SH, Fowke JH.

PLoS One. 2015 Jul 9;10(7):e0132028. doi: 10.1371/journal.pone.0132028. eCollection 2015.

3.

Assessing the Influence of Benign Prostatic Hyperplasia (BPH) on Erectile Dysfunction (ED) among patients in Poland.

Dutkiewicz S, SkawiƄski D, Duda W, Duda M.

Cent European J Urol. 2012;65(3):135-8. doi: 10.5173/ceju.2012.03.art7. Epub 2012 Sep 4.

4.

Should modest elevations in prostate-specific antigen, International Prostate Symptom Score, or their rates of increase over time be used as surrogate measures of incident benign prostatic hyperplasia?

Schenk JM, Hunter-Merrill R, Zheng Y, Etzioni R, Gulati R, Tangen C, Thompson IM, Kristal AR.

Am J Epidemiol. 2013 Sep 1;178(5):741-51. doi: 10.1093/aje/kwt044. Epub 2013 Jun 28.

5.

Impact of type 2 diabetes on lower urinary tract symptoms in men: a cohort study.

Van Den Eeden SK, Ferrara A, Shan J, Jacobsen SJ, Quinn VP, Haque R, Quesenberry CP.

BMC Urol. 2013 Feb 20;13:12. doi: 10.1186/1471-2490-13-12.

6.

Relationship between serum sex hormones levels and degree of benign prostate hyperplasia in Chinese aging men.

Zeng QS, Xu CL, Liu ZY, Wang HQ, Yang B, Xu WD, Jin TL, Wu CY, Huang G, Li Z, Wang B, Sun YH.

Asian J Androl. 2012 Sep;14(5):773-7. doi: 10.1038/aja.2012.32. Epub 2012 Jul 2.

7.

Effectiveness of medical and surgical therapies for lower urinary tract symptoms in the community setting.

Krambeck AE, Jacobson DJ, McGree ME, Lightner DJ, Lieber MM, Jacobsen SJ, St Sauver JL.

BJU Int. 2012 Nov;110(9):1332-7. doi: 10.1111/j.1464-410X.2012.10998.x. Epub 2012 Apr 3.

8.

Evaluating racial/ethnic disparities in lower urinary tract symptoms in men.

Van Den Eeden SK, Shan J, Jacobsen SJ, Aaronsen D, Haque R, Quinn VP, Quesenberry CP Jr; Urologic Diseases in America Project.

J Urol. 2012 Jan;187(1):185-9. doi: 10.1016/j.juro.2011.09.043. Epub 2011 Nov 17.

9.

Association between socioeconomic status (SES) and lower urinary tract symptom (LUTS) severity among black and white men.

Fowke JH, Munro H, Signorello LB, Blot WJ, Penson DF; Urologic Diseases of America Project.

J Gen Intern Med. 2011 Nov;26(11):1305-10. doi: 10.1007/s11606-011-1776-8. Epub 2011 Jul 1.

10.

Race and socioeconomic status are independently associated with benign prostatic hyperplasia.

Fowke JH, Murff HJ, Signorello LB, Lund L, Blot WJ.

J Urol. 2008 Nov;180(5):2091-6; discussion 2096. doi: 10.1016/j.juro.2008.07.059. Epub 2008 Sep 18.

11.
12.

Metabolic factors associated with benign prostatic hyperplasia.

Parsons JK, Carter HB, Partin AW, Windham BG, Metter EJ, Ferrucci L, Landis P, Platz EA.

J Clin Endocrinol Metab. 2006 Jul;91(7):2562-8. Epub 2006 Apr 11.

Supplemental Content

Support Center